The Certara Blog

Author: Bill Poland

Dr. Bill Poland is a Vice President and lead scientist at Certara. He has provided pharmaceutical companies guidance in drug development decisions through scientific and decision-analytic modeling and simulation since he joined Certara in 1998. In over 40 projects for top pharmaceutical companies, he has advised on trial and program design for HCV, HIV, and other therapeutic areas, using integrated treatment adherence, pharmacokinetic, pharmacodynamic, and trial models.

Recent Posts

Population Modeling Helps Predict the Impact of E-cigarettes on Health

The Oxford Dictionaries 2014 Word of the Year is “vape” – to inhale and exhale the vapor produced by an electronic cigarette (also known as e-cigarette or e-cig) or similar device. This choice reflects the meteoric rise in e-cig popularity. E-cigs, which deliver nicotine without carcinogenic tar, hold the promise to save the lives of […]

Read More
Learn More LinkedIn Twitter Facebook Email